Application of machine learning methods in clinical trials for precision medicine

Yizhuo Wang(Harbin Medical University), Xuelin Huang(The University of Texas MD Anderson Cancer Center), Bing Z. Carter(The University of Texas MD Anderson Cancer Center), Ziyi Li(The University of Texas MD Anderson Cancer Center)
JAMIA Open
January 7, 2022
10.1093/jamiaopen/ooab107
Cited by 35

Related Papers

An improvement of the 2ˆ(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis.
|PubMed|2013|1.6k
Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia
|Blood|2006|691
Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study
|The Lancet Oncology|2016|405
Association of Measurable Residual Disease With Survival Outcomes in Patients With Acute Myeloid Leukemia
|JAMA Oncology|2020|380
DNA Methylation Predicts Survival and Response to Therapy in Patients With Myelodysplastic Syndromes
|Journal of Clinical Oncology|2009|359